Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

321 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The ARRONAX project.
Haddad F, Barbet J, Chatal JF. Haddad F, et al. Among authors: barbet j. Curr Radiopharm. 2011 Jul;4(3):186-96. doi: 10.2174/1874471011104030186. Curr Radiopharm. 2011. PMID: 22201708 Review.
ARRONAX, a high-energy and high-intensity cyclotron for nuclear medicine.
Haddad F, Ferrer L, Guertin A, Carlier T, Michel N, Barbet J, Chatal JF. Haddad F, et al. Among authors: barbet j. Eur J Nucl Med Mol Imaging. 2008 Jul;35(7):1377-87. doi: 10.1007/s00259-008-0802-5. Epub 2008 May 9. Eur J Nucl Med Mol Imaging. 2008. PMID: 18465127
What can be expected from nuclear medicine tomorrow?
Barbet J, Kraeber-Bodéré F, Chatal JF. Barbet J, et al. Cancer Biother Radiopharm. 2008 Aug;23(4):483-504. doi: 10.1089/cbr.2008.010-U. Cancer Biother Radiopharm. 2008. PMID: 18771353 Review.
Radiolabeled antibodies for cancer imaging and therapy.
Barbet J, Bardiès M, Bourgeois M, Chatal JF, Chérel M, Davodeau F, Faivre-Chauvet A, Gestin JF, Kraeber-Bodéré F. Barbet J, et al. Methods Mol Biol. 2012;907:681-97. doi: 10.1007/978-1-61779-974-7_38. Methods Mol Biol. 2012. PMID: 22907380 Review.
Tumor immunotargeting using innovative radionuclides.
Kraeber-Bodéré F, Rousseau C, Bodet-Milin C, Mathieu C, Guérard F, Frampas E, Carlier T, Chouin N, Haddad F, Chatal JF, Faivre-Chauvet A, Chérel M, Barbet J. Kraeber-Bodéré F, et al. Among authors: barbet j. Int J Mol Sci. 2015 Feb 11;16(2):3932-54. doi: 10.3390/ijms16023932. Int J Mol Sci. 2015. PMID: 25679452 Free PMC article. Review.
Sensitivity and prognostic value of positron emission tomography with F-18-fluorodeoxyglucose and sensitivity of immunoscintigraphy in patients with medullary thyroid carcinoma treated with anticarcinoembryonic antigen-targeted radioimmunotherapy.
Oudoux A, Salaun PY, Bournaud C, Campion L, Ansquer C, Rousseau C, Bardet S, Borson-Chazot F, Vuillez JP, Murat A, Mirallié E, Barbet J, Goldenberg DM, Chatal JF, Kraeber-Bodéré F. Oudoux A, et al. Among authors: barbet j. J Clin Endocrinol Metab. 2007 Dec;92(12):4590-7. doi: 10.1210/jc.2007-0938. Epub 2007 Sep 18. J Clin Endocrinol Metab. 2007. PMID: 17878252 Clinical Trial.
Bifunctional antibodies for radioimmunotherapy.
Chatal JF, Faivre-Chauvet A, Bardies M, Peltier P, Gautherot E, Barbet J. Chatal JF, et al. Among authors: barbet j. Hybridoma. 1995 Apr;14(2):125-8. doi: 10.1089/hyb.1995.14.125. Hybridoma. 1995. PMID: 7590767 Review.
321 results